Surface immobilisation of native glycosaminoglycans (GAGS) in a 96-well format.
No modification of GAG necessary.
Protein binding properties retained.
Versatile and simple to use.
Amenable to high throughput screening.
Binds GAGs at room temperature using physiological buffers.
Binds a wide range of GAGs; from fully sulphated heparin to non-sulphated hyaluronan from high molecular weight polysaccharides down to decasaccharides.
